- Home
- HTOO vs IMRN Comparison
HTOO vs IMRN Comparison
Compare HTOO & IMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HTOO
- IMRN
- Stock Information
- Founded
- HTOO 2020
- IMRN 1994
- Country
- HTOO Ireland
- IMRN Australia
- Employees
- HTOO N/A
- IMRN N/A
- Industry
- HTOO Natural Gas Distribution
- IMRN Biotechnology: Pharmaceutical Preparations
- Sector
- HTOO Utilities
- IMRN Health Care
- Exchange
- HTOO Nasdaq
- IMRN Nasdaq
- Market Cap
- HTOO 7.7M
- IMRN 9.2M
- IPO Year
- HTOO N/A
- IMRN N/A
- Fundamental
- Price
- HTOO $4.68
- IMRN $2.16
- Analyst Decision
- HTOO
- IMRN
- Analyst Count
- HTOO 0
- IMRN 0
- Target Price
- HTOO N/A
- IMRN N/A
- AVG Volume (30 Days)
- HTOO 393.5K
- IMRN 73.4K
- Earning Date
- HTOO 02-28-2023
- IMRN 08-29-2025
- Dividend Yield
- HTOO N/A
- IMRN N/A
- EPS Growth
- HTOO N/A
- IMRN N/A
- EPS
- HTOO N/A
- IMRN N/A
- Revenue
- HTOO $10,024,662.00
- IMRN $4,777,422.00
- Revenue This Year
- HTOO $4,832.46
- IMRN N/A
- Revenue Next Year
- HTOO $81.82
- IMRN N/A
- P/E Ratio
- HTOO N/A
- IMRN N/A
- Revenue Growth
- HTOO 105.98
- IMRN 48.63
- 52 Week Low
- HTOO $3.41
- IMRN $1.50
- 52 Week High
- HTOO $30.45
- IMRN $2.73
- Technical
- Relative Strength Index (RSI)
- HTOO 53.75
- IMRN 71.29
- Support Level
- HTOO $4.57
- IMRN $2.15
- Resistance Level
- HTOO $5.42
- IMRN $2.30
- Average True Range (ATR)
- HTOO 0.49
- IMRN 0.09
- MACD
- HTOO 0.02
- IMRN 0.03
- Stochastic Oscillator
- HTOO 49.23
- IMRN 74.47
About HTOO Fusion Fuel Green PLC
Fusion Fuel Green PLC is a provider of full-service energy engineering and advisory solutions, specializing in green hydrogen and industrial gas applications. It offers a broad portfolio of services, including the design, supply, installation, and maintenance of energy systems, as well as the transport and distribution of liquefied petroleum gas. The company serves a diverse customer base spanning commercial buildings, mixed-use developments, heavy industries, and food service sectors. The group currently derives revenue by providing comprehensive solutions for the liquefied petroleum gas (LPG) industry, which includes the supply, installation, and maintenance of LPG systems, as well as transportation and delivery of LPG in both bulk and cylinder formats.
About IMRN Immuron Limited
Immuron Ltd is a commercial and clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.